BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32428305)

  • 1. Method development and validation of LC-MS/MS-based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and its application in pharmacokinetic study.
    Gui LL; Li L; Dong LH; Xiang SS; Zhai JP; Ge ZQ; Song HF
    Biomed Chromatogr; 2020 Dec; 34(12):e4903. PubMed ID: 32428305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum.
    Jiang H; Zeng J; Titsch C; Voronin K; Akinsanya B; Luo L; Shen H; Desai DD; Allentoff A; Aubry AF; Desilva BS; Arnold ME
    Anal Chem; 2013 Oct; 85(20):9859-67. PubMed ID: 24024648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a liquid chromatography tandem mass spectrometry assay for the quantitation of a protein therapeutic in cynomolgus monkey serum.
    Zhao Y; Liu G; Angeles A; Hamuro LL; Trouba KJ; Wang B; Pillutla RC; DeSilva BS; Arnold ME; Shen JX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():81-7. PubMed ID: 25756208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab.
    Schokker S; Fusetti F; Bonardi F; Molenaar RJ; Mathôt RAA; van Laarhoven HWM
    MAbs; 2020; 12(1):1795492. PubMed ID: 32744170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab.
    Bults P; van der Voort A; Meijer C; Sonke GS; Bischoff R; van de Merbel NC
    Anal Bioanal Chem; 2022 Feb; 414(4):1513-1524. PubMed ID: 35001193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and simultaneous quantification of a mixture of biopharmaceuticals by a liquid chromatography/quadrupole time-of-flight mass spectrometric method in rat plasma following cassette-dosing.
    Park MH; Byeon JJ; Shin SH; Kim N; Park Y; Ill Lee B; Choi J; Shin YG
    Rapid Commun Mass Spectrom; 2018 Jun; 32(11):889-896. PubMed ID: 29578307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification and pharmacokinetic evaluation of roflumilast and its N-oxide in cynomolgus monkey plasma by LC-MS/MS method.
    Qu H; Zhang K; Fu C; Qiu F
    Biomed Chromatogr; 2021 Feb; 35(2):e4973. PubMed ID: 32840886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualification and application of a liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of trastuzumab in rat plasma.
    Park MH; Lee MW; Shin YG
    Biomed Chromatogr; 2016 Apr; 30(4):625-31. PubMed ID: 26317190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of a p38 MAP kinase inhibitor and its amide hydrolyzed metabolite in Cynomolgus monkey plasma by LC-MS/MS, and its application to a toxicokinetic study.
    Akrami A; Hsieh F; Almon V; Bruenner BA; James C; Wong P
    J Pharm Biomed Anal; 2011 Jul; 55(5):1104-10. PubMed ID: 21481559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a highly sensitive LC-MS/MS method for quantitation of bivalirudin in human plasma: application to a human pharmacokinetic study.
    Chai D; Wang R; Bai N; Cai Y; Liang B
    Biomed Chromatogr; 2013 Dec; 27(12):1788-93. PubMed ID: 23893840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reliable LC-MS/MS method for the quantification of N-acetyl-p-benzoquinoneimine, acetaminophen glutathione and acetaminophen glucuronide in mouse plasma, liver and kidney: Method validation and application to a pharmacokinetic study.
    Zhang X; Li R; Hu W; Zeng J; Jiang X; Wang L
    Biomed Chromatogr; 2018 Nov; 32(11):e4331. PubMed ID: 29978489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
    Sengottuvelan S; Uppal R; Vuppu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an LC-ESI-MS/MS method for the quantitation of hemslecin A in rhesus monkey plasma and its application in pharmacokinetics.
    Bai M; Li HL; He JC; He GH; Feng EF; Liu YQ; Shi PP; Xu GL
    Biomed Chromatogr; 2014 Mar; 28(3):385-90. PubMed ID: 24132644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC-MS/MS method for the quantitative analysis of the adenosine A2a receptor antagonist NIR178 and its monohydroxy metabolite in human plasma: Application to clinical pharmacokinetics.
    Heudi O; Plaud N; Aumonier C; Wu S; Hatsis P; Hurtado FK; Picard F; Winter S; Flarakos J
    Biomed Chromatogr; 2020 Oct; 34(10):e4909. PubMed ID: 32485782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an improved method for the quantitation of sertraline in human plasma using LC-MS-MS and its application to bioequivalence studies.
    Zhang M; Gao F; Cui X; Zhang Y; Sun Y; Gu J
    J Chromatogr Sci; 2011 Feb; 49(2):89-93. PubMed ID: 21223631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.